Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin in Recurrent or Metastatic Head and Neck Cancer
NCT00084682Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2005
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by National Cancer Institute. Started Jun 2005; status: completed.
02
Drugs
romidepsin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00084682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00084682.